N-(cyclopropyl(3-methylpyridin-2-yl)methyl)-7-propyl-1H-indole-2-carboxamide

ID: ALA5091341

PubChem CID: 166633010

Max Phase: Preclinical

Molecular Formula: C22H25N3O

Molecular Weight: 347.46

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CCCc1cccc2cc(C(=O)NC(c3ncccc3C)C3CC3)[nH]c12

Standard InChI:  InChI=1S/C22H25N3O/c1-3-6-15-8-4-9-17-13-18(24-20(15)17)22(26)25-21(16-10-11-16)19-14(2)7-5-12-23-19/h4-5,7-9,12-13,16,21,24H,3,6,10-11H2,1-2H3,(H,25,26)

Standard InChI Key:  LFLLZFBWAVDFFE-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 26 29  0  0  0  0  0  0  0  0999 V2000
   18.8311   -4.7834    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.8300   -5.6030    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.5380   -6.0119    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.5362   -4.3746    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.2449   -4.7798    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.2497   -5.5984    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.0297   -5.8469    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.5070   -5.1818    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.0219   -4.5224    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   19.5338   -3.5574    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.3242   -5.1769    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.7370   -5.8822    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   22.7286   -4.4668    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   23.5458   -4.4620    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.9502   -3.7519    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.9586   -5.1673    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.9634   -5.9845    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.6687   -5.5717    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.7682   -3.7498    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   25.1726   -3.0405    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.7598   -2.3342    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.9384   -2.3417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.5377   -3.0515    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.7206   -3.0591    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.8249   -3.1509    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.8224   -2.3337    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9  5  1  0
  4 10  1  0
  8 11  1  0
 11 12  2  0
 11 13  1  0
 13 14  1  0
 14 15  1  0
 14 16  1  0
 17 16  1  0
 18 17  1  0
 16 18  1  0
 15 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 15  1  0
 23 24  1  0
 10 25  1  0
 25 26  1  0
M  END

Alternative Forms

  1. Parent:

    ALA5091341

    ---

Associated Targets(Human)

SETD2 Tchem Histone-lysine N-methyltransferase SETD2 (119 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 347.46Molecular Weight (Monoisotopic): 347.1998AlogP: 4.70#Rotatable Bonds: 6
Polar Surface Area: 57.78Molecular Species: NEUTRALHBA: 2HBD: 2
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 4.57CX LogP: 4.56CX LogD: 4.56
Aromatic Rings: 3Heavy Atoms: 26QED Weighted: 0.68Np Likeness Score: -0.67

References

1. Lampe JW, Alford JS, Boriak-Sjodin PA, Brach D, Cosmopoulos K, Duncan KW, Eckley ST, Foley MA, Harvey DM, Motwani V, Munchhof MJ, Raimondi A, Riera TV, Tang C, Thomenius MJ, Totman J, Farrow NA..  (2021)  Discovery of a First-in-Class Inhibitor of the Histone Methyltransferase SETD2 Suitable for Preclinical Studies.,  12  (10.0): [PMID:34671445] [10.1021/acsmedchemlett.1c00272]

Source